ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2025
Concurrent TMS-EEG to characterize cortical responses in the motor and prefrontal cortices in Parkinson's disease.
Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Natural Frequencies of Levodopa-Induced Dyskinesia in Parkinson's Disease.Annals of clinical and translational neurology · 2026Article
- Hydrogels in Neurological Disorders: Emerging Diagnostic and Therapeutic Applications.International journal of nanomedicine · 2026Review
- Extracting reproducible components from electroencephalographic responses to transcranial magnetic stimulation with group task-related component analysis.Imaging neuroscience (Cambridge, Mass.)Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with Parkinson's disease (PD) experience both motor and non-motor symptoms. However, it remains unclear the full spectrum of PD, which requires a comprehensive assessment of both motor and non-motor cortical regions. The use of combined transcranial magnetic stimulation and electroencephalography (TMS-EEG) allows the examination of neural circuit beyond motor cortex. In this study, TMS-EEG data were collected over the primary motor cortex (M1) and dorsolateral prefrontal cortex (DLPFC) in 46 patients with PD and 27 healthy controls (HC). We analyzed TMS-evoked potentials and oscillatory powers to identify differences in cortical excitability and neural connectivity dynamics between the two cohorts. Patients with PD exhibited higher P30 amplitude following M1 stimulation compared to HCs, and there was a positive correlation between P30 amplitude and the severity of motor symptoms. DLPFC stimulation revealed an increased global mean field amplitude area under the curve (GMFA-AUC) at P30 and P60 in the PD group compared to HCs. A significant correlation was also observed within the PD group between P30 and P60 with depression scores. In addition, PD showed a significant power reduction in the alpha and beta bands during stimulation and distinct patterns emerged for each stimulation site. These findings provide novel insights into cortical network abnormalities and contribute to a better understanding of the mechanisms underlying PD.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.